| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |